XVIVO PERFUSION AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 419 SEK | +8.55% |
|
+2.82% | +27.16% |
| Apr. 24 | Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest | DJ |
| Apr. 24 | Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024 |
Evolution of the average Target Price on Xvivo Perfusion AB
Price target over the last 5 years
History of analyst recommendation changes
a08b5686794470e302f7a3e.tvckDQNOGrnz8r_vt1LMdwYxSeirRHFEREpCUYBzGZA.w7RiRDF5UsO-neaXmjSHD3xhBID0aTIzBj0yfNFKetbUsko1OiNT8JSAiw~b45493ae0832556f6140a093bbc4b541
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
386
SEK
Average target price
408
SEK
Spread / Average Target
+5.70%
High Price Target
468
SEK
Spread / Highest target
+21.24%
Low Price Target
340
SEK
Spread / Lowest Target
-11.92%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B
EPS Revisions
- Stock Market
- Equities
- XVIVO Stock
- Consensus Xvivo Perfusion AB
